Armistice Capital’s Medicus Pharma Warrant MDCXW Stock Holding History

Armistice Capital’s Portfolio MDCXW Stock Details MDCXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57.6K	Hold	60,600	–	–	﹤0.01%	251
2025 Q4	$48.5K	Hold	60,600	–	–	﹤0.01%	354
2025 Q3	$43.6K	Hold	60,600	–	–	﹤0.01%	322
2025 Q2	$53.5K	Hold	60,600	–	–	﹤0.01%	190
2025 Q1	$42.4K	Buy	+60,600	New	+$62.8K	﹤0.01%	213

Other funds holding MDCXW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Armistice Capital's MDCXW Position: Q1 2026 in Review

Armistice Capital held its Medicus Pharma Warrant (MDCXW) position steady in Q1 2026 at 60,600 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #251.

Armistice Capital first reported a position in MDCXW in Q1 2025 and has held it in 5 quarters since. 6 funds tracked by Wall St. Rank hold MDCXW as of Q1 2026.

Armistice Capital held 60,600 shares of Medicus Pharma Warrant worth $57.6K as of Q1 2026.
Armistice Capital left its Medicus Pharma Warrant share count unchanged in Q1 2026.
Medicus Pharma Warrant made up ﹤0.01% of Armistice Capital's portfolio in Q1 2026, its #251 holding.
Armistice Capital first reported a position in Medicus Pharma Warrant in Q1 2025 and has held it in 5 quarters since.
6 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.